Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adoptive Immunotherapy
10%
Allogeneic HLA
20%
Anti-CD3 Antibody
10%
Anti-HLA
10%
Antigen Stimulation
10%
Ascites
10%
Autologous Tumors
100%
Breast Cancer Patients
10%
Chromium Release Assay
10%
Clinical Applicability
10%
Cytotoxic T Lymphocytes
100%
Cytotoxicity
100%
Derived Peptide
20%
Enhanced Cytotoxicity
10%
Epidermal Growth Factor Receptor
10%
Her2neu
100%
HLA-A2
60%
Human Tumor Cells
10%
Immunogenic
10%
In Vitro Activation
100%
In Vitro Cytotoxicity
10%
Interleukin-2
30%
Lymphocyte Stimulation
10%
Monoclonal Antibody
10%
Oncogene
10%
Ovarian Cancer Patients
20%
Ovarian Tumor
100%
Peptide Antigen
20%
Peptide Epitopes
10%
Recombinant interleukin-2
10%
Solid Phase
10%
Synthetic Peptides
10%
T Cells
10%
Therapeutic Vaccine
10%
Transmembrane Protein
10%
Tumor
20%
Tumor Antigen
10%
Tumor Cells
30%
Tumor-associated
10%
Tumor-associated Lymphocytes
100%
Vaccine Therapy
10%
Medicine and Dentistry
Adoptive Immunotherapy
10%
Ascites
10%
Autologous Tumor Cell
10%
Breast Cancer
10%
Cancer Antibody
10%
CD3 Antibody
10%
Cell Culture
10%
Chromium Release Assay
10%
Cytotoxic T-Cell
100%
Cytotoxicity
100%
Epidermal Growth Factor Receptor
10%
Epitope
10%
Immunostimulation
10%
In Vitro
100%
Interleukin 2
30%
Lymphocyte
100%
Lymphocyte Activation
10%
Monoclonal Antibody
10%
Ovarian Cancer
10%
Ovarian Tumor
100%
Proto Oncogene
10%
Recombinant Interleukin 2
10%
Synthetic Peptide
10%
T Lymphocyte
10%
Tumor
100%
Tumor Antigen
10%
Tumor Cell
30%